Home » Topics » BioWorld Science

BioWorld Science
RSS

Indirect targeting can affect serine production

Sep. 27, 2019

Sunshine Lake Pharma patents MAO-B inhibitors

Sep. 26, 2019

Vaxart reports phase Ib data on oral bivalent norovirus vaccine

Sep. 26, 2019

Beijing Scitech-Mq Pharmaceuticals divulges EGFR and HER2 inhibitors

Sep. 26, 2019

Tyme Technologies begins pivotal stage of TYME-88-Panc trial with SM-88

Sep. 26, 2019

Celgene International II Sarl synthesizes new PDE4 inhibitors

Sep. 26, 2019

AzurRx reports phase II results for MS-1819 for exocrine pancreatic insufficiency in cystic fibrosis

Sep. 26, 2019

Phase IIa study of EDP-305 in NASH meets primary endpoint

Sep. 26, 2019

PharmaResources discloses new HBV antivirals

Sep. 26, 2019

Inflazome divulges new NLRP3 inhibitors

Sep. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...